PAY VERSUS PERFORMANCE
The following table sets forth the compensation for Ron Kurtz, M.D., our principal executive officer (“PEO”), and the average compensation for our named executive officers other than our PEO (“non-PEO NEOs”) for fiscal years 2025, 2024, 2023, and 2022 (each a “covered year”), both as reported in the Summary Compensation Table and with certain adjustments to reflect the “compensation actually paid” to such individuals, as calculated in accordance with rules adopted by the SEC in August 2022. “Compensation actually paid” does not reflect amounts actually realized by our PEO and Non-PEO NEOs and may be higher or lower than amounts, if any, that are actually realized by such individuals. The table below also provides information for each Covered Year regarding our cumulative total shareholder return, the total shareholder return of the S&P Healthcare & Supplies Index, our net income and our revenue.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of Initial Fixed $100 |
|
|
|
|
|
||||||||||
Year |
|
Summary Compensation |
|
|
Compensation Actually |
|
|
Average Summary Compensation Table Total for Non-PEO NEOs ($)(1) |
|
|
Average Compensation Actually Paid to Non-PEO NEOs ($)(1)(2)(3) |
|
|
Total Shareholder |
|
Peer Group Total Shareholder Return ($) (4) |
|
Net Income ($) |
|
Revenue |
|
||||||||
2025 |
|
|
4,650,661 |
|
|
|
(2,156,420 |
) |
|
|
2,484,868 |
|
|
|
(1,327,953 |
) |
|
|
92.62 |
|
|
76.03 |
|
|
(38.9 |
) |
|
134.5 |
|
2024 |
|
|
6,982,453 |
|
|
|
5,115,927 |
|
|
|
5,804,227 |
|
|
|
4,221,090 |
|
|
|
305.60 |
|
|
76.22 |
|
|
(27.5 |
) |
|
139.9 |
|
2023 |
|
|
3,081,597 |
|
|
|
11,796,221 |
|
|
|
1,808,267 |
|
|
|
6,263,724 |
|
|
|
358.40 |
|
|
72.30 |
|
|
(48.6 |
) |
|
89.1 |
|
2022 |
|
|
1,025,471 |
|
|
|
1,245,648 |
|
|
|
649,355 |
|
|
|
762,518 |
|
|
|
112.62 |
|
|
76.64 |
|
|
(66.8 |
) |
|
49.0 |
|
2022-2024 |
|
2025 |
Shelley Thunen |
|
Shelley Thunen |
Eric Weinberg |
|
Eric Weinberg |
Ilya Goldshleger, Ph.D. |
|
Ilya Goldshleger, Ph.D. |
|
|
Scott Gaines |
Fiscal Year |
|
2025 |
|
|
|
Summary Compensation Table Total for PEO ($) |
|
|
4,650,661 |
|
|
Minus Grant Date Fair Value of Equity Awards in Summary Compensation Table ($) |
|
|
(3,816,530 |
) |
|
Plus Year End Fair Value of Equity Awards Granted During Year That are Outstanding and Unvested at Fiscal Year End ($) |
|
|
1,023,383 |
|
|
Minus Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($) |
|
|
(2,508,864 |
) |
|
Plus Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($) |
|
|
327,561 |
|
|
Plus Change in Fair Value between the Vesting Date and the End of the Prior Year of Equity Awards Granted in Prior Years that Vested in the Year ($) |
|
|
(1,832,631 |
) |
|
Minus Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($) |
|
|
— |
|
|
Compensation Actually Paid to PEO ($) |
|
|
(2,156,420 |
) |
|
Fiscal Year |
|
2025 |
|
|
|
Average Summary Compensation Table Total for Non-PEO NEOs ($) |
|
|
2,484,868 |
|
|
Minus Non-PEO NEO Average Grant Date Fair Value of Equity Awards in Summary Compensation Table ($) |
|
|
(1,890,240 |
) |
|
Plus Non-PEO NEO Average Year End Fair Value of Equity Awards Granted During Year That are Outstanding and Unvested at Fiscal Year End ($) |
|
|
548,908 |
|
|
Minus Non-PEO NEO Average Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($) |
|
|
(1,722,997 |
) |
|
Plus Non-PEO NEO Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($) |
|
|
160,516 |
|
|
Plus Non-PEO NEO Average Year over Year Change in Fair Value between the Vesting Date and the End of the Prior Year of Equity Awards Granted in Prior Years that Vested in the Year ($) |
|
|
(909,008 |
) |
|
Minus Non-PEO NEO Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($) |
|
|
— |
|
|
Average Compensation Actually Paid to Non-PEO NEOs ($) |
|
|
(1,327,953 |
) |
|
2022-2024 |
|
2025 |
Shelley Thunen |
|
Shelley Thunen |
Eric Weinberg |
|
Eric Weinberg |
Ilya Goldshleger, Ph.D. |
|
Ilya Goldshleger, Ph.D. |
|
|
Scott Gaines |
Tabular List of Financial Performance Measures
The following list presents the financial performance measures that the Company considers to have been the most important in linking Compensation Actually Paid to our PEO and Non-PEO NEOs for 2025 to Company Performance. The measures in this list are not ranked.